Research Progress of Polysaccharides and Cancer Treatment
DOI:
https://doi.org/10.54097/hset.v36i.6275Keywords:
Cancer treatment, polysaccharides, anti-tumor therapy.Abstract
Over the past decade, scientists have already discovered several methods for cancer treatment, however, most of the treatments have various kinds of negative side effects. Researchers have focused on creating medications with few adverse effects for cancer because it is one of the most fatal diseases. Due to their anti-tumor properties and non-toxic attributes, bioactive macromolecules like polysaccharides are seen as viable options against cancer. Nowadays, there have been many studies on the mechanisms and possibilities of polysaccharides against tumors, and this paper attempts to summarize the progress and main problems achieved so far in polysaccharides against cancer. This article will start from these aspects, the idea of cancer treatment, how cancer affects the immune system, how polysaccharides are absorbed and processed, how they are used in anti-tumor therapy, and how they work are all covered in the current review. Future therapeutic research will place a high priority on polysaccharides since they have the potential to be significant therapeutic targets.
Downloads
References
National Cancer Institute. “What Is Cancer?” National Cancer Institute, Cancer.gov, 5 May 2021, www.cancer.gov/about-cancer/understanding/what-is-cancer.
Mayo Clinic. “Cancer Treatment - Mayo Clinic.” Mayoclinic.org, 4 June 2020, www.mayoclinic.org/tests-procedures/cancer-treatment/about/pac-20393344.
“Chemotherapy: What You Need to Know | UVA Health.” Uvahealth.com, uvahealth.com/services/cancer/chemotherapy.
Zeng, Yujun, et al. “Polysaccharide-Based Nanomedicines for Cancer Immunotherapy: A Review.” Bioactive Materials, vol. 6, no. 10, Oct. 2021, pp. 3358–3382, 10.1016/j.bioactmat.2021.03.008. Accessed 9 May 2022.
Ale, Marcel Tutor, et al. “Fucoidan from Sargassum Sp. And Fucus Vesiculosus Reduces Cell Viability of Lung Carcinoma and Melanoma Cells in Vitro and Activates Natural Killer Cells in Mice in Vivo.” International Journal of Biological Macromolecules, vol. 49, no. 3, 1 Oct. 2011, pp. 331–336, pubmed.ncbi.nlm.nih.gov/21624396/, 10.1016/j.ijbiomac.2011.05.009. Accessed 11 Nov. 2020.
Miao, Ying, et al. “Growth Inhibition and Cell-Cycle Arrest of Human Gastric Cancer Cells by Lycium Barbarum Polysaccharide.” Medical Oncology, vol. 27, no. 3, 11 Aug. 2009, pp. 785–790, 10.1007/s12032-009-9286-9. Accessed 28 Nov. 2022.
Fadeel, Bengt, et al. “Programmed Cell Clearance: Molecular Regulation of the Elimination of Apoptotic Cell Corpses and Its Role in the Resolution of Inflammation.” Biochemical and Biophysical Research Communications, vol. 396, no. 1, May 2010, pp. 7–10, 10.1016/j.bbrc.2010.02.106. Accessed 2 Oct. 2020.
Vallabhapurapu, Subrahmanya D., et al. “Variation in Human Cancer Cell External Phosphatidylserine Is Regulated by Flippase Activity and Intracellular Calcium.” Oncotarget, vol. 6, no. 33, 9 Oct. 2015, pp. 34375–34388, 10.18632/oncotarget.6045. Accessed 26 Aug. 2022.
Ostwald, Thomas J., and David H. MacLennan. “Isolation of a High Affinity Calcium-Binding Protein from Sarcoplasmic Reticulum.” Journal of Biological Chemistry, vol. 249, no. 3, Feb. 1974, pp. 974 – 979, 10.1016/s0021-9258(19)43026-3. Accessed 29 Nov. 2022.
Arosa, Fernando A., et al. “Calreticulin Is Expressed on the Cell Surface of Activated Human Peripheral Blood T Lymphocytes in Association with Major Histocompatibility Complex Class I Molecules.” Journal of Biological Chemistry, vol. 274, no. 24, June 1999, pp. 16917–16922, 10.1074/jbc.274.24.16917. Accessed 9 June 2022.
Gardai, Shyra J., et al. “Cell-Surface Calreticulin Initiates Clearance of Viable or Apoptotic Cells through Trans-Activation of LRP on the Phagocyte.” Cell, vol. 123, no. 2, 21 Oct. 2005, pp. 321–334, pubmed.ncbi.nlm.nih.gov/16239148/, 10.1016/j.cell.2005.08.032. Accessed 3 Aug. 2022.
Lemieszek, Marta, and Wojciech Rzeski. “Anticancer Properties of Polysaccharides Isolated from Fungi of the Basidiomycetes Class.” Współczesna Onkologia, vol. 4, 2012, pp. 285–289, 10.5114/wo.2012.30055.
Bao, Xingfeng, et al. “Chemical Modifications of the (1→3)-α-d-Glucan from Spores of Ganoderma Lucidum and Investigation of Their Physicochemical Properties and Immunological Activity.” Carbohydrate Research, vol. 336, no. 2, Nov. 2001, pp. 127–140, 10.1016/s0008-6215(01)00238-5. Accessed 29 Nov. 2022.
Borchers, Andrea T., et al. “Mushrooms, Tumors, and Immunity.” Proceedings of the Society for Experimental Biology and Medicine, vol. 221, no. 4, Aug. 1999, pp. 281–293, 10.1046/j.1525-1373. 1999.d01-86. x. Accessed 6 Feb. 2022.
Ross, Gordon D, et al. “Therapeutic Intervention with Complement and β-Glucan in Cancer.” Immunopharmacology, vol. 42, no. 1-3, May 1999, pp. 61–74, 10.1016/s0162-3109 (99)00013 - 2. Accessed 29 Nov. 2022.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
